Welcome — and thank you for being one of the first people to open this. I started BH Leadership Brief for a simple reason: I wanted one quick, easy to read place that pulled together everything new in behavioral health that actually touches my job — and left out everything that doesn't. I spend my days as a leader on the inpatient psych side of behavioral healthcare, where a CMS rule change, a payer's prior-auth shift, or an unfilled psychiatrist line isn't theoretical — it directly shapes my everyday decision making. This is the read I always wanted: one place that pulls the federal and Colorado policy moves, the clinical and pharmacological developments, the technology and AI shifts, and the workforce signals worth knowing, and quietly skips the rest. No filler, no explaining your own job back to you — just the week's intelligence, sorted by what it changes for your operation, in about ten minutes. I'm glad you're here. Let's get into it.

Weekly intelligence for behavioral health leaders: policy, clinical innovation, technology, workforce, and the week ahead.

CMS released an applied behavior analysis oversight toolkit on August 4, and Colorado is the state the reporting keeps naming. Medicaid and CHIP spending on ABA rose 421% between 2021 and 2025 while the number of children with an autism diagnosis receiving services grew 67%. The toolkit hands state Medicaid and CHIP agencies a checklist across clinical standards, benefit design, payment methodology, provider enrollment, credentialing, utilization management, and program integrity, built from more than 40 literature sources and more than 240 state policy references. CMS says it sets no new federal requirements and doesn’t reduce EPSDT obligations. A New York Times investigation cited in the coverage found Colorado Medicaid spent more on children’s autism therapy last year than on emergency department care for every patient in the program (CMS, August 4; Becker’s Behavioral Health, August 4).

Implication: A 421% spending line is how a payer builds the case for its next utilization review program, and behavioral health sits directly behind autism in that queue. If you run or contract for ABA, find out this month which of those seven domains your state already audits. CMS and Colorado-relevant.

The Medicaid community engagement rule took effect July 31, and the comment file closed the same day under organized clinical opposition. CMS-2454-IFC conditions eligibility for certain adults on 80 hours a month of work or community engagement, with state compliance beginning January 1, 2027. The American Medical Association filed July 29 arguing the rule “departs from Congress’s intent,” and America’s Physician Groups and the Primary Care Collaborative filed on July 31. The Legal Action Center, joined by 89 other organizations, said the rule narrows the “medically frail” exemption past what Congress enacted and creates documentation and verification duties that providers will absorb (AAHD policy roundup, August 4; Legal Action Center, July 31).

Implication: Your social work and utilization review staff will end up documenting exemptions for patients who qualify on paper and can’t produce the paper. Decide before October who owns the medically frail attestation at discharge, because January 1 is a coverage cliff rather than a filing deadline. CMS-relevant.

Louisiana now requires a behavioral health evaluation within 72 hours of every emergency certificate admission, effective August 1. A licensed professional has to evaluate for underlying behavioral conditions inside that window, and the hospital must contact the patient’s primary care or behavioral health provider to establish treatment history. Before discharge, the facility has to make a reasonable effort to notify those providers unless the patient objects, and refer the patient to behavioral and primary care services if none exists. The requirement applies specifically to inpatient behavioral healthcare delivered under an emergency certificate (Louisiana legislature, effective August 1, 2026; Becker’s Behavioral Health, August 7).

Implication: This is the shape state legislatures keep choosing: a clock on the evaluation and a documented handoff at discharge. Colorado hasn’t codified it, so treat the 72-hour evaluation and the notified-provider discharge note as the standard your next survey asks about anyway. Joint Commission-relevant.

Ninety organizations are asking CMS to withdraw a proposed cap on Medicaid provider payments benchmarked to Medicare. The Legal Action Center filed July 21 on Medicaid Managed Care State Directed Payments and fee-for-service targeted practitioner payments, arguing CMS lacks authority to cap either beyond what Congress authorized. Its core objection is the benchmark: Medicare doesn’t cover the full behavioral health continuum and under-reimburses much of what it does cover. Eighty-nine health and justice organizations endorsed the two letters (Legal Action Center, July 21 and July 31; Becker’s Behavioral Health, August 3).

Implication: State Directed Payments are how several states have propped up behavioral health rates without touching the base fee schedule. If yours does, model what a Medicare benchmark does to net Medicaid revenue per patient day before budget season, not during it. CMS-relevant.

Involuntary detention rates climbed 3.3% a year for a decade, and the strongest associations weren’t clinical. The August issue of Psychiatric Services carries a population-based analysis of 53,088 adult psychiatric detentions drawn from the Ontario Mental Health Reporting System between 2013 and 2023, across nine facilities holding roughly two-thirds of the province’s psychiatric beds. Involuntary admission accounted for 28.2% of hospitalizations and involuntary psychiatric assessment for 25.2%. Recent and long-term immigrants carried significantly higher odds of involuntary admission, post-secondary education lowered them, and Indigenous identity raised the odds of assessment but not of admission (Psychiatric Services, August 2026).

Operational read: Ontario law isn’t Colorado law, but a 3.3% annual climb over ten years is the curve most U.S. states are on, and almost nobody stratifies it by immigration or language status. Pull your own certification rate by primary language and interpreter use for the last four quarters, because that’s the version of this finding your quality committee can act on.

A muscarinic agent controlled agitation in treatment-refractory bipolar I with psychosis, in a case published August 5. The report describes rapid agitation control and functional improvement with xanomeline/trospium in a patient who had failed standard dopaminergic treatment, which is the population driving your one-to-one hours. Real-world and pooled long-term data presented at APA 2026 and covered July 30 show reduced hospitalizations and lower antipsychotic burden in schizophrenia, alongside cardiometabolic and urinary adverse event rates. A first-in-vivo PET study published July 29 found M1 receptor availability reduced 13% to 19% across brain regions in schizophrenia (Psychiatric Times, August 5, July 30, and July 29).

Operational read: One case report doesn’t move a formulary. What moves it is an accumulating agitation signal for a non-dopaminergic agent in a population your P&T committee currently treats with dopamine blockade and a boxed warning, so ask pharmacy to open a file now.

Psychiatric Times published a postpartum psychosis clinical FAQ on August 6, built around early recognition and lithium-centered treatment. The piece separates postpartum OCD intrusive thoughts from delusions, which is the distinction that decides whether a patient goes home or gets admitted. It ran two days after an August 3 analysis of the Lindsay Clancy case examining how stigma and DSM gaps delay recognition, and in the same week the journal named suicide its August theme. Both pieces treat the presentation as a psychiatric emergency rather than an obstetric complication (Psychiatric Times, August 6 and August 3).

Operational read: Your emergency department and OB consult teams see this a handful of times a year, which is exactly why the triage decision drifts. Put the OCD-versus-delusion distinction into your perinatal consult checklist before the next one arrives at 2 a.m.

Colorado’s AI restrictions take effect Wednesday, and the penalty runs to $20,000 per violation. House Bill 26-1195 bars AI from directly engaging in therapeutic communication, requires written informed consent before AI records or transcribes a session, and limits licensed clinicians to supplementary and administrative uses under provider oversight. Unlawful provision or advertising of AI psychotherapy is an unfair trade practice under the Colorado Consumer Protection Act, carrying civil penalties up to $20,000 each. The statute carves out accredited education and training programs and research supervised by a federally registered institutional review board (Colorado HB 26-1195, enacted June 3, effective August 12, 2026).

Implication: Written consent before recording is the provision that touches every ambient documentation pilot in the state on Wednesday. If your consent form doesn’t name AI transcription, you don’t have consent, and the penalty attaches per violation rather than per program. Colorado-relevant.

Amae Health started routing wearable data into psychiatric care teams on August 4, aimed at predicting relapse in serious mental illness. The collaboration with Google Health Enterprise feeds sleep, physical activity, heart rate variability, and disruption of daily routine from Fitbit and the Google Health app to clinicians treating schizophrenia, bipolar disorder, major depressive disorder, and severe personality disorders. Chief Medical Officer Scott Fears, MD, framed it as objective measurement of disease progression in a specialty that has never had a scalable biomarker. Amae says it’s working toward a composite mental health score modeled on cardiac risk scoring, with no timeline disclosed, and already holds clinical relationships with Cedars-Sinai, Mass General Brigham, and NewYork-Presbyterian (Psychiatric Times, August 4; Amae Health news release, August 4).

Implication: Relapse prediction that runs on sleep and activity data lands on your readmission numbers before it shows up on anyone’s outpatient dashboard. Ask your outpatient partners what passive monitoring they’re piloting, because a 30-day readmission a wearable flagged on day nine is a conversation you want to have first.

The VA has lost more than 300 psychologists and 700 social workers since January 2025, plus roughly 200 psychiatrists in 2025 alone. More than 60 House members wrote Secretary Doug Collins on July 28, citing 2025 data in which 57% of VA facilities reported severe psychology staffing shortages. The letter asks for vacancy counts, provider separations, recruitment and retention efforts, wait times, and continuity-of-care measures, and cites reports of longer waits, canceled appointments, and interrupted treatment. The VA’s response is due August 14 (Rep. Judy Chu’s office, July 28; Becker’s Behavioral Health, August 7).

Workforce read: Every clinician who leaves the VA lands in your applicant pool or a competitor’s, and every veteran who loses a VA therapist eventually shows up in a community crisis system. Ask your recruiter whether they’re actively sourcing VA separations, because more than 1,200 licensed behavioral health clinicians changed employers in nineteen months and most of them stayed in the field.

Adult psychiatrist supply is projected to fall 12.3% by 2037 while demand rises 43.7%. The projection comes from a 2026 workforce study in Psychiatric Services covering 2024 through 2037, summarized in an August 6 market analysis. Workforce adequacy, meaning the share of projected demand the supply can actually meet, drops from 70.2% in 2024 to 42.8% in 2037, with steeper gaps in rural and underserved states. The same analysis names clinician recruitment and retention as the factor acquirers now underwrite psychiatry deals on (Psychiatric Services 2026;77(6); Psychiatric Times, August 6).

Workforce read: 42.8% adequacy is the number to put in front of your board when you argue for a psychiatric nurse practitioner pipeline instead of another locums renewal. Model your medical staff to 2032 rather than to next fiscal year, because that curve is already priced into what you’re paying today.

Federal regulators still aren’t enforcing the 2024 parity rule, and the consolidation it was meant to counterbalance keeps moving. The Departments of Labor, HHS, and Treasury said in May 2025 they wouldn’t enforce the MHPAEA final rule provisions while industry litigation proceeds, and signaled a revised rule instead. Universal Health Services has since agreed to acquire Talkspace for roughly $835 million, while Talkiatry raised a $210 million Series D and Grow Therapy raised $150 million in early 2026. Scaled outpatient platforms now command high-single to low-double-digit EBITDA multiples against mid-single digits for single-site practices (Psychiatric Times, August 6).

Workforce read: Non-enforcement means your denial appeals rest on contract language and medical necessity criteria rather than on a federal comparative analysis you can demand. Get your denial-overturn rate by payer in front of your CFO before the next contract cycle opens.

•      August 12: Colorado House Bill 26-1195 takes effect. Written consent before AI records or transcribes a session, no AI in therapeutic communication, and civil penalties up to $20,000 per violation under the Colorado Consumer Protection Act. Colorado-relevant.

•      August 14: The VA’s response is due to the July 28 House letter on behavioral health workforce reductions. If the vacancy and wait-time figures are released, they’re the best public benchmark for psychiatric staffing you will get this year.

•      August 17: SAMHSA applications close on three CCBHC funding opportunities: Planning, Development and Implementation (SM-26-014), Improvement and Advancement (SM-26-015), and State Planning (SM-26-016), all posted June 17. If a provider in your catchment lands one, your step-down referral map changes without your input.

•      August 20, 9 a.m. MT: The Colorado BHA Advisory Council meets on its standing third-Thursday cadence, open to the public. CCBHC demonstration timelines and ASAM Criteria alignment are the items worth listening for. Colorado BHA-relevant.

•      September 1: Colorado HCPF moves neurological and psychological testing codes off the behavioral health fee schedule to the Health First Colorado fee schedule. Three weeks out, and it’s the next Colorado billing change after the August 1 supportive services denials. Colorado HCPF-relevant.

CMS just showed the country what it does with a 421% spending line, and inpatient psychiatric days are one dataset away from the same treatment.

Sources

–    CMS, “CMS Launches New State Toolkit to Protect Children with Autism, Strengthen Oversight of Applied Behavior Analysis,” August 4, 2026

–    Becker’s Behavioral Health, “CMS unveils autism care toolkit after 421% spending increase,” August 4, 2026

–    American Association on Health and Disability, policy roundup, week of August 4, 2026 (AMA comment letter July 29, 2026; America’s Physician Groups and Primary Care Collaborative comment letters July 31, 2026)

–    CMS, Medicaid Community Engagement Requirement for Certain Individuals, Interim Final Rule with Comment Period (CMS-2454-IFC), effective July 31, 2026; compliance beginning January 1, 2027

–    Legal Action Center, comment letters on Medicaid State Directed Payments (July 21, 2026) and the community engagement interim final rule (July 31, 2026), endorsed by 89 organizations

–    Becker’s Behavioral Health, “90 advocacy groups warn CMS rules threaten behavioral healthcare access,” August 3, 2026

–    Becker’s Behavioral Health, “24 state behavioral health policy updates,” August 7, 2026 (Louisiana inpatient behavioral health admission and discharge requirements effective August 1, 2026)

–    Psychiatric Services, “Social Determinants and Trends in Involuntary Psychiatric Detentions: A Decade of Population-Based Data,” August 2026 issue

–    Psychiatric Times, “Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report,” August 5, 2026

–    Psychiatric Times, “Real-World and Long-Term Trial Data Show Xanomeline/Trospium Cuts Hospitalizations, Antipsychotic Burden in Schizophrenia,” July 30, 2026; “PET Imaging Confirms Lower Muscarinic M1 Receptor Availability in Schizophrenia,” July 29, 2026

–    Psychiatric Times, “FAQ: What Clinicians Need to Know About Postpartum Psychosis,” August 6, 2026; “Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us,” August 3, 2026

–    Colorado House Bill 26-1195, enacted June 3, 2026, effective August 12, 2026; Colorado Consumer Protection Act civil penalties

–    Psychiatric Times, “Bringing Wearable Data Into Psychiatric Care: Amae Health Partners With Google Health Enterprise,” August 4, 2026; Amae Health news release, August 4, 2026

–    Becker’s Behavioral Health, “60+ House Democrats press VA on mental healthcare staffing gaps,” August 7, 2026; letter to VA Secretary Doug Collins, July 28, 2026

–    Psychiatric Times, “Psychiatry Mid-Year Market Update 2026,” August 6, 2026; Psychiatric Services 2026;77(6), adult psychiatry workforce projections

–    U.S. Departments of Labor, Health and Human Services, and the Treasury, statement on non-enforcement of the MHPAEA final rule, May 15, 2025

–    SAMHSA, CCBHC funding opportunities SM-26-014, SM-26-015, and SM-26-016, posted June 17, 2026, applications due August 17, 2026

–    Colorado Department of Health Care Policy & Financing, July 2026 Provider Bulletin (B2600540), fee schedule changes effective September 1, 2026

Make sure to subscribe so you don’t miss the next newsletter and you stay informed on the updates shaping behavioral healthcare in Colorado and the nation.